Hepatitis E is caused by hepatitis E virus (HEV) that is generally manifested by a self-limiting acute infection as well as fulminant liver failure in about 20--30% of pregnant women in developing countries ([@bib0005], [@bib0070]). Very recently, a challenging clinical situation associated with chronic hepatitis E in immunocompromised individuals has emerged in some industrialized nations ([@bib0075]). Classified as the only member of the *Hepeviridae* family, HEV has at least four recognized genotypes. In addition to humans, genotypes 1 and 2 can also infect non-human primates while genotypes 3 and 4 are further infectious to swine and few other mammalian species ([@bib0065]). The virus is non-enveloped with a positive-sense, single-stranded RNA genome of approximately 7200 bases that contains three partially overlapping open reading frames (ORFs): ORF1, ORF2 and ORF3 ([@bib0115]). HEV ORF2 codes for the viral capsid glycoprotein while ORF3 translates into a small phosphoprotein, attributed to some host-regulatory functions, including establishing infection and virion egress ([@bib0015], [@bib0035], [@bib0120]). Viral ORF1 is 5109 bases long and encodes the nonstructural polyprotein of ∼186 kDa, essential for RNA replication ([@bib0125]). [@bib0055] had proposed six putative domains (N- to C-terminal) of methyltransferase (MetT), papain-like cysteine protease (PCP), RNA helicase (Hel/NTPase), RNA-dependent RNA polymerase (RdRp), including undefined X and Y.

Extensive attempts have been made to study ORF1 processing and validate the viral PCP-domain proteolytic activity using cell-free, prokaryotic and eukaryotic expression systems. Expression of a full-length ORF1 in transiently-transfected HepG2 cells had resulted in an intact ∼186 kDa protein while a recombinant vaccinia virus-expressed ORF1 had produced two fragments of ∼107 and ∼78 kDa in cultured mammalian cells that was, however, attributed to non-HEV proteases ([@bib0095]). Furthermore, an infectious HEV RNA-transfected HepG2 cells produced distinct processed products of ORF1, identified as ∼35, ∼38 and ∼36 kDa bands with anti-MetT, anti-Hel and anti-RdRp antibodies, respectively ([@bib0085]). The processing of an ORF1-fusion polyprotein by detecting eight cleaved-products was also reported in a recombinant baculovirus-insect cell expression system that could be inhibited by a cysteine-protease inhibitor (E-64d) ([@bib0100]). The study by [@bib0100], however, did not conclude whether the ORF1 proteolysis occurred due to HEV- or host-encoded protease. Nevertheless, the role of ORF1 PCP-domain in HEV RNA replication remains elusive or/and controversial. In this present report, we have, therefore, addressed this issue through a systematic molecular analysis of ORF1 gene, using HEV-SAR~55~ genomic-replicon system and expression of ORF1-fusion protein in cultured S10-3 cells.

ORF1 polyprotein sequences of HEV strains (*n*  = 77) as well as that of genetically-close rubella virus (RUBV) was analyzed *in silico*. A total of 32 ORF1 mutants (Group-I: amino acid mutants; Group-II: sequential nucleotide mutants) of *pSK-GFP* (HEV-SAR~55~; genotype 1 genomic-replicon) were constructed by site-directed mutagenesis. In the present case, the HEV ORF2 coding sequence had been swapped with that of green fluorescent protein (GFP) and GFP production was used to monitor viral replication ([@bib0025]). Briefly, mutant primer-sets were designed and commercially synthesized (Invitrogen, USA) followed by PCR amplification of *pSK-GFP* as per manufacturer\'s instructions (TaKaRa Biotech., Japan). The Dpn*I*-digested PCR DNA products were transformed (heat-shock) into XL-blue competent cells (Stratagene, USA). Mutant plasmids were confirmed by DNA sequencing (Invitrogen, USA) and stock DNA were prepared (Qiagen Plasmid Maxi-prep Kit, Germany). Cultures of human S10-3 cells were maintained as previously described ([@bib0030]) and were seeded (0.5 × 10^6^ cells/well, in duplicate), in a 12-well culture plate. The Bgl*II*-linearized pSK-GFP constructs were transcribed *in vitro* and transfected into S10-3 cells, essentially as described elsewhere ([@bib0025]). All transfected cells were observed for GFP production on day six by fluorescence microscopy (FM) (Zeiss). S10-3 cultures transfected with wild-type replicon (*pSK-GFP-WT*) showed approximately 50% GFP(+) cells and served as positive control while those receiving polymerase-mutant replicon (*pSK-GFP-GAD*) were GFP(−) and included as negative control ([Fig. 1](#fig0005){ref-type="fig"}A). Of the PCP-domain (aa. 433--592) constructs (Group-I: eight 'Cys→Ala' and four 'His→Leu' mutants), six 'Cys' (C457A, C459A, C471A, C472A, C481A, C483A) and three 'His' (H443L, H497L, H590L) mutants completely abolished RNA replication ([Fig. 1](#fig0005){ref-type="fig"}B, left panel). Notably, of these essential 'Cys' and 'His' residues, C483 and H590 had been previously predicted as putative 'catalytic' residues in PCP-domain ([@bib0055]). This was, however, in contrast with mutational analysis of the universally conserved C483 that did not affect ORF1 processing ([@bib0095]). However, the non-conserved H590 mutant 'H590L' completely aborted the RNA replication. Further, all PCP-domain group-II mutants (nts. 1340--1801; *n*  = 7) that had conserved amino acid sequences allowed production of GFP comparable to wild-type culture ([Fig. 1](#fig0005){ref-type="fig"}B, left panel). This confirmed the functional role of PCP-domain 'Cys' and 'His' residues in HEV replication at protein level. The above lethal mutant-replicons were double-checked for reproducibility of the results.Fig. 1The *ex vivo* replication profiles (FM) of HEV replicon-constructs. (A) Replication of control replicons, representing the mutant constructs translated into GFP(+) or GFP (−) S10-3 cells. (B) Replication of ORF1 PCP-domain (*n* = 19) and X-domain (*n* = 13) mutants (Group-I: amino acid mutants; Group-II: sequential nucleotide mutants; \* [@bib0055], [@bib0095]).

HEV is most closely related to the rubivirus genera of the Togaviridae family of positive-sense, single-stranded RNA viruses where proteolytic processing of viral polyprotein occurs through recognizing a cleavage-site. The RUBV polyprotein cleavage-substrate, a 'Gly' triad (G1299-G1300-G1301), downstream of protease-domain has been characterized ([@bib0020]). The HEV ORF1 sequence homology search identified a similar 'G815-G816-G817'^′^ sequence in the X-domain, downstream of PCP-domain~.~ A further multiple alignment of HEV partial sequences showed a highly conserved 'Gly--Gly--Gly(GGG)' triplet in X-domain ([Fig. 2](#fig0010){ref-type="fig"}A). Therefore, X-domain mutant replicons (Group-1: three'Gly→Val' mutants; Group-II: sequential nucleotide mutants) were constructed and tested for their role, if any, in viral RNA replication. Of the group-I constructs, while G816V and G817V mutants completely abrogated, the first 'Gly' mutant (G815A) allowed the viral replication ([Fig. 1](#fig0005){ref-type="fig"}B, right panel). The group-II mutants (nts. 2396--2910; *n*  = 10) had no significant effects on viral RNA replication ([Fig. 1](#fig0005){ref-type="fig"}B, right panel) and, thus, excluded any regulatory role of X-domain at transcriptional level. This suggested that the HEV 'G815-G816-G817' amino acid sequence could act as a substrate for ORF1 proteolysis, analogous to RUBV nonstructural polyprotein-substrate ([Fig. 2](#fig0010){ref-type="fig"}B). Thus, an important role of X-domain sequences in HEV replication is discovered. Very recently, an *in vitro* deubiquitination activity of HEV 'MetT-PCP' co-domains through recognizing coronavirus consensus 'L-X-G-G' substrates in ORF1 has been described ([@bib0045]). Although the *E. coli* expressed 'MBP-Met-PCP' fusion-protein significantly hydrolyzed non-viral substrates, like IFN-stimulated gene 15 (ISG15), there was no proteolysis of viral 'Hel-RdRp' protein. It was further demonstrated that HEV replication requires active ubiquitin-proteosome machinery and that could be blocked by proteosome-inhibitors without affecting host translations ([@bib0050]). However, these studies did not directly address the viral PCP-domain 'enzymatic' and 'L-X-G-G' substrate activities in ORF1 processing or RNA replication. In contrast, the present *ex vivo* study has precisely identified and confirmed indispensability of ORF1 PCP-domain 'catalytic' and X-domain putative 'protease-substrate' residues in HEV replication.Fig. 2A. ORF1 polyprotein amino acid sequence (partial) alignment of 77 HEV strains (GeneBank accession numbers: AB074918, AB074920, AB089824, AY575857, AY575858, AY575859, AF082843, AF060669, AY115488, AB091394, AB222182, AB246676, AB222183, AB236320, AB189071, AB189072, AB189074, AB189073, AB189075, AB189070, AP003430, AB222184, AB073912, AB248521, AB248522, AB248520, AF455784, AB074917, AB220972, AB161719, AB161718, AB220973, AB220975, AB220978, AB220977, AB220979, AB220976, AB161717, AB074915, AB091395, AB200239, AB099347, AB193176, AB097811, AB193177, AB193178; AB097812; AB220971; AB080575; AB220974; AB108537; DQ450072; AB197674, EF077630, AB197673, AY723745, AJ272108, AY594199, AB253420, DQ279091, AF028091, AF076239, AF459438, AF051830, X99441, D10330, M73218, AF444002, AF444003, L25547, L25595, L08816, M94177, D11093, X98292, AY230202 and M74506), representing genotypes 1, 2, 3 and 4. The conserved 'G815-G816-G817' triplet in ORF1 X-domain is shown (box). B. X-domain putative protease-substrate homology with that of RUBV where viable (green) and lethal mutations (red) are shown.

Despite ample reports on processing of ORF1 polyprotein, validity of a biochemically distinct and functional viral protease remains another bottle-neck in the understanding of HEV biology. To further address this, ORF1 (HEV-SAR~55~) was amplified with '*HA*' and '*His*' epitope tagged-primer sets, using *pSK-HEV* as template and cloned into EcoR*1*/Xho*I* site of *pTriEx-1.1* expression vector (Novagen, USA). The resulting vector (*pTriEx-ORF1*) was verified by DNA sequencing that could translate *5'HA-ORF1-His-3*' in frame with vector-start/stop codon. *In vitro* translated product of *pTriEx-ORF1* (TNT coupled transcription--translation kit, Promega, USA) was immuneprecipitated (IP) with anti-HA and anti-His antibodies (Promega, USA) and subjected to Western blot (WB) analysis as described elsewhere ([@bib0080]). An expected single band of ∼191 kDa comparable to native ORF1 was detected ([Fig. 3](#fig0015){ref-type="fig"}A) that was in line with earlier cell-free/*in vitro* studies. Further, the *ex vivo* synthesis of ORF1 and its expected processing was analyzed in *pTriEx-ORF1* tranfected S10-3 cells. In brief, 100 mm dishes of S10-3 cultures were transfected with 20 μg DNA, using fugene-6 (Promega, USA). Briefly, duplicated cultures were physically harvested and pooled at 72 h in cold PBS containing phenylmethylsulfonyl fluoride and EDTA-free protease inhibitor cocktail (Boehringer Mannheim, Germany). The cell pellet was incubated on ice for about 15--20 min and disrupted in a Dounce homogenizer ([@bib0060]), followed by concentrating (protein concentrator, 20 kDa cut-off) of the post-nuclear supernatant. IP/WB analysis of the total protein allowed detection of a small N-terminal fragment of ∼35 kDa with anti-HA ([Fig. 3](#fig0015){ref-type="fig"}B) and a C-terminal peptide of ∼78 kDa with anti-His antibody ([Fig. 3](#fig0015){ref-type="fig"}C), indicating ORF1 polyprotein processing *ex vivo*. The two peptides were in conformity with the same that had been detected previously ([@bib0085], [@bib0100], [@bib0095]). The present findings are, however, in contrast with a previous study where ORF1 expressed from a swine HEV infectious cDNA clone in non-hepatic 293T cells has not shown proteolysis ([@bib0105]). Also, in a very recent study, expressions of HEV full-length ORF1 and six truncated variants in human cervical HeLa and hepatic Huh-7 cells do not support the predicted PCP-domain ([@bib0090]).Fig. 3IP/WB analysis of HEV ORF1 expression and processing. (A) *In vitro* translation (anti-HA) showing a band of ∼191 kDa (lanes 1: *pTriEx1.1*and 2: *pTriEx-ORF1*). (B) *Ex vivo* synthesis in S10-3 cells (anti-HA) showing a band of ∼35 kDa\* (lanes 1: *pTriEx1.1*, 2: *pTriEx-ORF1*and 3: standard protein marker). (C) *Ex vivo* synthesis in S10-3 cells (anti-His) showing a band of ∼78 kDa\* (lanes 1: *pTriEx-ORF1*, 2: *pTriEx-1.1*, and 3: standard protein marker) (\*[@bib0085], [@bib0100]; \*\*[@bib0095]).

Expression and purification of HEV protease and, therefore, its biochemical or biophysical characterization is not achieved so far. In view of this and based on earlier reports in consort with recent findings, functionality of HEV ORF1-encoded protease was quite convincing and favored by the present data. Nevertheless, these findings are in agreement with earlier reports on ORF1 processing, endorsed by Karpe et al. (2011; 2012) strongly support an ORF1-encoded protease essential for HEV replication. On the other hand, a possible role of host-encoded protease(s) in viral life cycle cannot be ignored. A universal validation of viral protease would have an important implication for the classification of HEV within the positive-strand RNA virus group as well as understanding its biology.
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